Europe Heparin Market Size & Outlook, 2023-2030
Europe heparin market, 2018-2030 (US$M)
Related Markets
Europe heparin market highlights
- The Europe heparin market generated a revenue of USD 2,092.6 million in 2023.
- The market is expected to grow at a CAGR of 2.2% from 2024 to 2030.
- In terms of segment, porcine was the largest revenue generating source in 2023.
- Bovine is the most lucrative source segment registering the fastest growth during the forecast period.
- Country-wise, France is expected to register the highest CAGR from 2024 to 2030.
Europe data book summary
| Market revenue in 2023 | USD 2,092.6 million |
| Market revenue in 2030 | USD 2,441.7 million |
| Growth rate | 2.2% (CAGR from 2023 to 2030) |
| Largest segment | Porcine |
| Fastest growing segment | Bovine |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Porcine, Bovine |
| Key market players worldwide | Pfizer Inc, Sanofi SA, Aspen Pharmacare Holdings Ltd, Fresenius SE & Co KGaA, Novartis AG ADR, GSK PLC ADR, Dr. Reddy’s Laboratories, LEO Pharma, B. Braun Medical |
Other key industry trends
- In terms of revenue, Europe region accounted for 28.3% of the global heparin market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 2,436.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Heparin Market Scope
Heparin Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe heparin market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to heparin market will help companies and investors design strategic landscapes.
Porcine was the largest segment with a revenue share of 89.54% in 2023. Horizon Databook has segmented the Europe heparin market based on porcine, bovine covering the revenue growth of each sub-segment from 2018 to 2030.
Europe is the second-largest market for heparin in the world. Increasing prevalence of chronic diseases is indirectly driving market growth. Associations such as the Plasma Protein Therapeutic Association (PPTA) are actively involved in manufacturing quality plasma-derived products and distributing source plasma. Surgical procedures are in high demand in the region.
For instance, in 2017, 1.7 million C-section procedures were performed in EU countries, which is 4 times likely to cause blood clots than vaginal delivery. Surgeries also lead to lack of movement, thus, increasing chances of creating blood clots.
Thus, prescribing drugs such as heparin becomes crucial. In addition, as per the International Diabetes Federation in 2019, over 59.32 million individuals suffered from diabetes in the region, which is expected to act as a market driver.
Reasons to subscribe to Europe heparin market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe heparin market databook
-
Our clientele includes a mix of heparin market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe heparin market , including forecasts for subscribers. This continent databook contains high-level insights into Europe heparin market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe heparin market size, by country, 2018-2030 (US$M)
Europe Heparin Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
